Type Here to Get Search Results !

FDA Holds Back MDMA Psychedelic Therapy Over Safety, Efficacy Concerns

A close-up of the United States Food and Drug

Lykos, the developer of the MDMA-assisted therapy for PTSD, called the FDA's request for more phase 3 research "deeply disappointing."

from Gizmodo https://ift.tt/Q3d42eK
via IFTTT
Tags

Post a Comment

0 Comments
* Please Don't Spam Here. All the Comments are Reviewed by Admin.